NCT04805437

Brief Summary

Idiopathic scoliosis is the most common spinal deformity in children and adolescents with an estimated prevalence of 3%. About one tenth of the children with scoliosis develop a deformity that requires treatment with brace or surgery with the current treatment protocol. When brace treatment for scoliosis is indicated, standard treatment consists of bracing 20 hours or more per day. Outcomes of brace treatment depend to a large extent on wearing time and since many adolescents feel uncomfortable in the brace, it is of importance to combine efficacy and comfortability of the brace.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
170

participants targeted

Target at P75+ for not_applicable

Timeline
132mo left

Started Apr 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress32%
Apr 2021Apr 2037

First Submitted

Initial submission to the registry

March 13, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 18, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

April 30, 2021

Completed
6.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2027

Expected
9.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2037

Last Updated

February 21, 2025

Status Verified

February 1, 2025

Enrollment Period

6.3 years

First QC Date

March 13, 2021

Last Update Submit

February 20, 2025

Conditions

Keywords

Idiopathic scoliosisRandomized controlled trialBraceOrthosis

Outcome Measures

Primary Outcomes (1)

  • Curve progression

    Increase in curve severity (Cobb angle) of more than 6 degrees on two consecutive radiographs after baseline

    Measured at each six-month follow-up until skeletal maturity. Skeletal maturity defined as less than 1 cm body height increase in 6 months.

Secondary Outcomes (6)

  • Clinical outcomes

    At each six-month follow-up and 2, 5, 10 years after skeletal maturity

  • Patient-reported outcome measures

    At each six-months follow-up and 2, 5, 10 years after skeletal maturity

  • Patient-reported outcome measures

    At each six-month follow-up, and 2, 5, 10 years after skeletal maturity

  • Patient-reported outcome measures

    At each six-month follow-up, and 2, 5, 10 years after skeletal maturity

  • Patient-reported outcome measures

    At each six-month follow-up, and 2, 5, 10 years after skeletal maturity

  • +1 more secondary outcomes

Study Arms (2)

3D TLSO

EXPERIMENTAL

A 3-dimensional Boston brace will be designed to the patient's individual type of scoliosis. In-brace radiographs will be performed after prescription. Reinforcement of the assigned intervention will be performed in conjunction with reassessment every 6 months. Patients are encouraged to use the brace for 20 hours per day and to also continue with physical activities for the entirety of the study. Compliance will be monitored with a heat sensor built in the brace that measures wearing time.

Device: 3D TLSO

Standard TLSO

ACTIVE COMPARATOR

A standard Boston brace will be designed to the patient's individual type of scoliosis. In brace radiographs will be performed after prescription. Reinforcement of the assigned intervention will be performed in conjunction with reassessment every 6 months. Patients are encouraged to use the brace for 20 hours per day and to also continue with physical activities for the entirety of the study. Compliance will be monitored with a heat sensor built in the brace that measures wearing time.

Device: Standard TLSO

Interventions

3D TLSODEVICE

Brace treatment with Boston 3D 20 hours a day until skeletal maturity.

Also known as: Boston 3D brace
3D TLSO

Brace treatment with standard Boston brace 20 hours a day until skeletal maturity.

Also known as: Boston brace
Standard TLSO

Eligibility Criteria

Age9 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Cobb 25-40 degrees
  • Skeletally immature, Sanders score of 6 or less and Risser 2 or less.
  • Menarche status maximum one year in females
  • Aged 9-17 years
  • No previous brace treatment or surgery for scoliosis
  • Apex of the primary curve at T7 or caudal

You may not qualify if:

  • Non-idiopathic scoliosis (i.e. neuromuscular, syndromic or congenital scoliosis)
  • Previous spine surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Linköping university hospital

Linköping, Sweden

NOT YET RECRUITING

Karolinska university hospital

Stockholm, Sweden

RECRUITING

Related Publications (1)

  • Diarbakerli E, Charalampidis A, Abbott A, Gerdhem P. PReventing Idiopathic SCOliosis PROgression (PRISCOPRO): A protocol for a quadruple-blinded, randomized controlled trial comparing 3D designed Boston brace to standard Boston brace. PLoS One. 2021 Aug 9;16(8):e0255264. doi: 10.1371/journal.pone.0255264. eCollection 2021.

Study Officials

  • Elias Diarbakerli, PT, PhD

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Elias Diarbakerli, PT, PhD

CONTACT

Paul Gerdhem, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Orthotist and research nurse will know what type of brace the participant receives, but will not tell the participant which type he/she has received. Investigators, care providers and outcome assessors will be blinded for type of brace.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 13, 2021

First Posted

March 18, 2021

Study Start

April 30, 2021

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

April 1, 2037

Last Updated

February 21, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

IPD underlying published manuscripts will be accessible for other researchers.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
The study protocol will be submitted to a peer-reviewed journal.
Access Criteria
The investigators in charge will be responsible for reviewing access requests. Crude data, randomization procedures and intervention details can be shared with other researchers upon request.

Locations